Ashland, MA, United States of America

Bin Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Bin Li

Introduction

Bin Li is a notable inventor based in Ashland, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 2 patents to his name, his work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents, Bin Li has developed compounds related to heterocyclic nuclear hormone receptor modulators. The invention provides a compound of Formula (I) along with pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers thereof. These compounds are particularly useful for treating immunological and oncological conditions. Another patent focuses on novel compounds of Formula (I) that serve as kinase inhibitors, which can be beneficial in treating inflammatory conditions, diseases, and proliferative disorders, including cancers.

Career Highlights

Bin Li is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to contribute to innovative solutions in the pharmaceutical industry. His expertise in developing therapeutic compounds has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Bin Li has collaborated with several professionals, including Michael Z Hoemann and Gagandeep K Somal. These collaborations have further enhanced the scope and impact of his inventions.

Conclusion

In summary, Bin Li is an accomplished inventor whose work in pharmaceutical innovations has the potential to significantly improve treatment options for various medical conditions. His contributions continue to shape the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…